NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 50 of 61 results found.

Activity Company Description Location
Company StrideBio Inc. Activity: Research and Development Research and Development Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs). Location Research Triangle Park
Company Accord Healthcare Inc. Activity: Sales and Operations Sales and Operations Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. Location Durham
Company AegisCN LLC Activity: Research and Development Research and Development Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. Location Durham
Company Aestas Pharma Inc. Activity: Research and Development Research and Development Company Description Asetas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced. Location Durham
Company Alterna Therapeutics Inc. Activity: Research and Development Research and Development Company Description Alterna Therapeutics is developing first-in-class small molecules targeting the SHIP enzyme. Alterna is exploring its lead compounds in the areas of obesity, diabetes, bone marrow transplant and post-myeloblative therapy, cancer and Alzheimer's disease. Location Durham
Company Arrivo BioVentures LLC Activity: Research and Development Research and Development Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. Location Morrisville
Company Aruna Bio Activity: Research and Development Research and Development Company Description Aruna Bio develops neural exosomes for the treatment of neurodegenerative diseases. The company is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of therapeutics. Location Raleigh
Company AskBio Activity: Research and Development Research and Development Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. Location Research Triangle Park
Company Atrium Health Division of Therapeutic Research and Development Activity: Research and Development Research and Development Company Description The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research. Location Charlotte
Company Biogen Activity: Production and Manufacturing Production and Manufacturing Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. Its Drug Substance Campus in RTP is home to biologics production and a patient services contact center. Location Research Triangle Park
Company Biogen (Oral Solid Dose Facility) Activity: Production and Manufacturing Production and Manufacturing Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center. Location Research Triangle Park
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company Catalyst Medicine LLC Activity: Research and Development Research and Development Company Description Catalyst Medicine designs, develops and commercializes Class 1 and Class 2 medical devices in the areas of neurology, orthopedics, cardiology and plastic surgery. Location Durham
Company Cato SMS Activity: Contract Research and Testing Contract Research and Testing Company Description Cato SMS provides contract research services, including preclinical and clinical study design and management, regulatory assessments, data management and statistics, CMC program management, medical writing and submission of regulatory documents. Location Cary
Company Chaperone Therapeutics Inc. Activity: Research and Development Research and Development Company Description Chaperone Therapeutics develops disease-modifying therapies for neurodegenerative and rare diseases caused by protein misfolding. Location Durham
Company CLAIRIgen Activity: Research and Development Research and Development Company Description CLAIRIgen develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Clinipace Activity: Contract Research and Testing Contract Research and Testing Company Description Clinipace provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. Location Morrisville
Company Cloud Pharmaceuticals Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. Location Research Triangle Park
Company CogniKey Pharma LLC Activity: Contract Research and Testing Contract Research and Testing Company Description CogniKey Pharma develops drugs to treat cognitive impairment in CNS disorders. CogniKey has a special interest in the treatment of Mild Cognitive Impairment (MCI). Location Winston-Salem
Company Cognosci Inc. Activity: Research and Development Research and Development Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. Location Durham
Company Eisai Inc. Activity: Sales and Operations Sales and Operations Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company. Location Raleigh
Company ENVIGEN Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. Location Durham
Company Falcon Therapeutics Inc. Activity: Research and Development Research and Development Company Description Falcon Therapeutics develops genetically distinct cell therapy to treat solid tumors by turning a patient's own skin cells into "Trilogy Cells" that seek out and destroy cancer cells. Location Durham
Company GBM Pharma Inc. Activity: Research and Development Research and Development Company Description GBM Pharma develops drugs for the treatment of glioblastoma multiforme. Location Durham
Company Generys Biopharmaceuticals Corp. Activity: Research and Development Research and Development Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. Location Chapel Hill
Company Grifols Activity: Sales and Operations Sales and Operations Company Description Grifols manufactures and markets plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. Location Research Triangle Park
Company GSK Activity: Research and Development Research and Development Company Description GSK develops and manufactures vaccines, medicines and consumer healthcare products, with a focus on science related to the immune system, use of genetics and advanced technologies. Location Research Triangle Park
Company Howard Associates LLC Activity: Contract Research and Testing Contract Research and Testing Company Description Howard Associates offers preclinical contract research to the pharma industry, primarily on rodent models to predict the efficacy of experimental compounds for CNS diseases and to predict side effects. The company also offers science editing and writing. Location Research Triangle Park
Company Ironshore Pharmaceuticals Inc. Activity: Sales and Operations Sales and Operations Company Description Ironshore Pharmaceuticals sells, markets and distributes a novel oral treatment for ADHD with delayed-release properties. Location Durham
Company Karamedica Inc. Activity: Research and Development Research and Development Company Description Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy. Location Raleigh
Company Krenitsky Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. Location Chapel Hill
Company LadeRx LLC Activity: Research and Development Research and Development Company Description LadeRx is developing new technology for diagnostic radiology. Location Durham
Company Merz Therapeutics Activity: Research and Development Research and Development Company Description Merz Therapeutics develops and commercializes neurological treatment solutions centered on movement disorders. Location Raleigh
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Durham
Company NeuroPro Therapeutics Inc. Activity: Research and Development Research and Development Company Description NeurPro Therapeutics is developing new drugs to treat epilepsy and other CNS disorders. Location Bahama
Company North Carolina Clinical Research Activity: Contract Research and Testing Contract Research and Testing Company Description North Carolina Clinical Research conducts phase one through four trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine and bioequivalent studies. Location Raleigh
Company Olfax LLC Activity: Research and Development Research and Development Company Description Olfax Medical is developing nasal drug delivery technologies. Location Asheville
Company Osmotica Pharmaceutical Corp. Activity: Research and Development Research and Development Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. Location Wilmington
Company PETNET Solutions Inc. (Winston-Salem) Activity: Production and Manufacturing Production and Manufacturing Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. Location Winston-Salem
Company PETNET Solutions Inc., A Siemens Healthineers Company Activity: Production and Manufacturing Production and Manufacturing Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. Location Durham
Company Pfizer Inc. (Chapel Hill) Activity: Research and Development Research and Development Company Description Pfizer's Bamboo Therapeutics develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases, including Giant Axonal Neuropathy (GAN), Canavan Disease, Friedreich's Ataxia and Duchenne Muscular Dystrophy (DMD). Location Chapel Hill
Company Pinnacle Hill LLC Activity: Research and Development Research and Development Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. Location Chapel Hill
Company Praetego Inc. Activity: Research and Development Research and Development Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes in conditions and diseases related to glucose dysregulation. Its primary focus is serious diabetic complications, and lead indication is Peripheral Neuropathy. Location Research Triangle Park
Company Resilio Therapeutics LLC Activity: Research and Development Research and Development Company Description Resilio Therapeutics is developing treatments for neurodegenerative diseases such as Alzheimer's Disease. Location Durham
Company Revivo Therapeutics Inc. Activity: Research and Development Research and Development Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. Location Durham
Company Roivant Sciences Inc. Activity: Research and Development Research and Development Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. Location Durham
Company RTI International Activity: Contract Research and Testing Contract Research and Testing Company Description RTI, an independent, nonprofit institute, offers scientific and technical expertise in social and laboratory sciences, engineering and international development to government and commercial clients worldwide. Location Research Triangle Park
Company Sentiens LLC Activity: Research and Development Research and Development Company Description Sentiens develops nutraceutical products targeting addictive behavior. Location Charlotte
Company SiNON Therapeutics Activity: Research and Development Research and Development Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). Location Durham
Company Sio Gene Therapies Activity: Research and Development Research and Development Company Description Sio Gene Therapies develops gene therapies to treat neurologic conditions. Location Durham